The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
pp60c-src activation in human colon carcinoma.
Open accessAbstract
We measured the in vitro protein-tyrosine kinase activity of pp60c-src from human colon carcinoma cell lines and tumors. The activity of pp60c-src from six of nine carcinoma cell lines was higher (on average, fivefold as measured by enolase phosphorylation, or eightfold as measured by autophosphorylation) than that of pp60c-src from normal colonic mucosal cells, or human or rodent fibroblasts. Similarly, the activity of pp60c-src from 13 of 21 primary colon carcinomas was five- or sevenfold higher than that of pp60c-src from normal colonic mucosa adjacent to the tumor. The increased pp60c-src activity did not result solely from an increase in the level of pp60c-src protein, suggesting the specific activity of the pp60c-src kinase is elevated in the tumor cells. pp60c-src from colon carcinoma cells and normal colonic mucosal cells was phosphorylated at similar sites. We used immunoblotting with antibodies to phosphotyrosine to identify substrates of protein-tyrosine kinases in colonic cells. Three phosphotyrosine-containing proteins were detected at significantly higher levels in most colon carcinoma cell lines than in normal colonic mucosal cells or human or rat fibroblasts. All colon carcinoma cell lines with elevated pp60c-src in vitro kinase activity, showed increased phosphorylation of proteins on tyrosine in vivo, suggesting the presence of an activated protein-tyrosine kinase(s).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Activation of SFKs occurs with high frequency during the development of CRC.”
From Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab (2011) · cites this paper as Cartwright et al., 1989
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An increase in SFK activity in CRC tumors as compared to normal adjacent mucosa has been reported (Bolen et al., 1987; Cartwright et al., 1989).”
From Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab (2011) · cites this paper as Cartwright et al., 1989
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., BOOM, J. H. V., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,674
Localization of the gene for familial adenomatous polyposis on chromosome 5
Bodmer, W. F., Bailey, C. J., Bodmer, J. G., Bussey, H. J. R., Ellis, A., Gorman, P. A., Lucibello, F. C., Murday, V. A., Rider, S. H., Scambler, P. J., et al. (1987) · Nature · doi:10.1038/328614a0 · Cited by 1,384
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., & Perucho, M. (1987) · Nature · doi:10.1038/327298a0 · Cited by 1,061
Expression of Cellular Oncogenes in Human Malignancies
Slamon, D. J., deKernion, J. B., Verma, I. M., & Cline, M. J. (1984) · Science · doi:10.1126/science.6538699 · Cited by 810
Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E., & Bishop, J. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.6.1707 · Cited by 761
The Gene for Familial Polyposis Coli Maps to the Long Arm of Chromosome 5
Leppert, M., Dobbs, M., Scambler, P. J., O'Connell, P., Nakamura, Y., Stauffer, D. M., Woodward, S. R., Burt, R. W., Hughes, J., Gardner, E., et al. (1987) · Science · doi:10.1126/science.3479843 · Cited by 671
Cited by
Sorted by citations
Role of Src expression and activation in human cancer
Irby, R., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 878
Src family kinases in tumor progression and metastasis
Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827
Kim, H., Jen, J., Vogelstein, B., & Hamilton, S. R. (1994) · PubMed Central · Cited by 809
Src in cancer: deregulation and consequences for cell behaviour
Frame, M. C. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00040-9 · Cited by 696
Activating SRC mutation in a subset of advanced human colon cancers
Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J. (1999) · Nature Genetics · doi:10.1038/5971 · Cited by 489
Selected glimpses into the activation and function of Src kinase
Bjorge, J. D., Jakymiw, A., & Fujita, D. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203923 · Cited by 415
Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.
Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116200 · Cited by 399
The Role of Src in Solid Tumors
Wheeler, D. L., Iida, M., & Dunn, E. F. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0009 · Cited by 346
Maa, M. C., Leu, T. H., McCarley, D. J., Schatzman, R. C., & Parsons, S. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6981 · Cited by 330
Bjorge, J. D., Pang, A., & Fujita, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004852200 · Cited by 321
Ottenhoff-Kalff, A. E., Rijksen, G., van Beurden, E. A., Hennipman, A. H., Michels, A. A., & Staal, G. E. J. (1992) · PubMed · Cited by 306
Protein tyrosine kinases and cancer
Kolibaba, K. S., & Druker, B. J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00022-x · Cited by 297
Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.
Cartwright, C. A., Meisler, A. I., & Eckhart, W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.558 · Cited by 277
Self-citationVerbeek, B. S., Feltkamp‐Vroom, T. M., Adriaansen-slot, S. S., Ottenhoff-Kalff, A. E., GEERTZEMA, J. G. N., Hennipman, A., & Rijksen, G. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199612)180:4 · Cited by 268
Chang, B. Y., Conroy, K. B., Machleder, E. M., & Cartwright, C. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3245 · Cited by 260
Self-citationActivation of Src kinase in primary colorectal carcinoma: An indicator of poor clinical prognosis
Allgayer, H., Boyd, D. D., Heiss, M. M., Abdalla, E. K., Curley, S. A., & Gallick, G. E. (2002) · Cancer · doi:10.1002/cncr.10221 · Cited by 251
c-Src, Receptor Tyrosine Kinases, and Human Cancer
Biscardi, J. S., Tice, D. A., & Parsons, S. J. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60774-5 · Cited by 243
Regulation of Src Family Kinases in Human Cancers
Sen, B., & Johnson, F. M. (2011) · Journal of Signal Transduction · doi:10.1155/2011/865819 · Cited by 235
Unni, E., Sun, S., Nan, B., McPhaul, M. J., Cheskis, B. J., Mancini, M. A., & Marcelli, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1121 · Cited by 233
Pogue-Geile, K., Geiser, J. R., Shu, M.-D., Miller, C., Wool, I. G., Meisler, A. I., & Pipas, J. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.3842 · Cited by 219
Self-citationSrc activation regulates anoikis in human colon tumor cell lines
Windham, T. C., Parikh, N. U., Siwak, D. R., Summy, J. M., McConkey, D. J., Kraker, A. J., & Gallick, G. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205989 · Cited by 219
Brunton, V. G., Avizienyte, E., Fincham, V. J., Serrels, B., Metcalf, C. A., Sawyer, T. K., & Frame, M. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1949 · Cited by 217
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
Camp, E. R., Summy, J. M., Bauer, T. W., Liu, W., Gallick, G. E., & Ellis, L. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.397.11.1 · Cited by 210
Oncolytic reovirus against ovarian and colon cancer.
Hirasawa, K., Nishikawa, S. G., Norman, K. L., Alain, T., Kossakowska, A. E., & Lee, P. W. K. (2002) · PubMed · Cited by 196
Baker, M. A., Hetherington, L., & Aitken, R. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03055 · Cited by 190
Lock, P., Abram, C. L., Gibson, T., & Courtneidge, S. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4346 · Cited by 180
Basuroy, S., Sheth, P., Kuppuswamy, D., Balasubramanian, S., Ray, R. M., & Rao, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211710200 · Cited by 181
Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling
Sandilands, E., Serrels, B., McEwan, D. G., Morton, J. P., Macagno, J. P., McLeod, K., Stevens, C., Brunton, V. G., Langdon, W. Y., Vidal, M., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2386 · Cited by 182
Biomarkers for early detection of colon cancer.
Srivastava, S. K., Verma, M., & Henson, D. E. (2001) · PubMed · Cited by 169
PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation
Zhu, S., Bjorge, J. D., & Fujita, D. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4338 · Cited by 168
Kang, K., Sun, W. T., Nomata, K., Morita, I., Cruz, A., Liu, C., Trosko, J. E., & Chang, C. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199804)21:4 · Cited by 43
SRC gene expression in human cancer: the role of transcriptional activation
Dehm, S. M., & Bonham, K. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-077 · Cited by 169
Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
Dunn, E. F., Iida, M., Myers, R. A., Campbell, D. A., Hintz, K. A., Armstrong, E. A., Li, C., & Wheeler, D. L. (2011) · Oncogene · doi:10.1038/onc.2010.430 · Cited by 133
“An increase in SFK activity in CRC tumors when compared with normal adjacent mucosa has been reported (Bolen et al., 1987; Cartwright et al., 1989).”
BackgroundElevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.
Cartwright, C. A., Coad, C. A., & Egbert, B. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117000 · Cited by 134
Self-citationAdhesion signaling by a novel mitotic substrate of src kinases
Bhatt, A. S., Erdjument‐Bromage, H., Tempst, P., Craik, C. S., & Moasser, M. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208582 · Cited by 135
Lesslie, D. P., Summy, J. M., Parikh, N. U., Fan, F., Trevino, J., Sawyer, T. K., Metcalf, C. A., Shakespeare, W. C., Hicklin, D. J., Ellis, L. M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603143 · Cited by 126
Irby, R., & Yeatman, T. J. (2002) · PubMed · Cited by 123
The Role of Src in Colon Cancer and Its Therapeutic Implications
Chen, J., Elfiky, A. A., Han, M., Chen, C., & Saif, M. W. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.10.003 · Cited by 129
c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis
Zhang, J., Wang, S., Jiang, B., Huang, L., Ji, Z., Li, X., Zhou, H.-M., Han, A., Chen, A., Wu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms13732 · Cited by 125
Serrels, A., Macpherson, I. R., Evans, T. R. J., Lee, F. Y., Clark, E. A., Sansom, O. J., Ashton, G. H. S., Frame, M. C., & Brunton, V. G. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0382 · Cited by 126
The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma
Offerhaus, G. J. A., Feyter, E. P. D., Cornelisse, C. J., Tersmette, K. W. F., Floyd, J. J., Kern, S. E., Vogelstein, B., & Hamilton, S. R. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91721-f · Cited by 116
BRK/Sik expression in the gastrointestinal tract and in colon tumors.
Llor, X., Serfas, M. S., Bie, W., Vasioukhin, V. I., Polonskaia, M., Derry, J. M. J., Abbott, C. M., & Tyner, A. L. (1999) · PubMed · Cited by 115
Src continues aging: current and future clinical directions
Kopetz, S., Shah, A. N., & Gallick, G. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1902 · Cited by 111
Lyn Kinase Activity Is the Predominant Cellular Src Kinase Activity in Glioblastoma Tumor Cells
Stettner, M. R., Wang, W., Nabors, B., Bharara, S., Flynn, D. C., Grammer, J. R., Gillespie, G. Y., & Gladson, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3688 · Cited by 111
Endosomal trafficking of Src tyrosine kinase
Sandilands, E., & Frame, M. C. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.05.004 · Cited by 109
Potential role of N-myristoyltransferase in cancer
Selvakumar, P., Lakshmikuttyamma, A., Shrivastav, A., Das, S. B., Dimmock, J. R., & Sharma, R. K. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.05.002 · Cited by 113
pp60c-src activation in lung adenocarcinoma
Masaki, T., Igarashi, K., Tokuda, M., Yukimasa, S., Han, F., Jin, Y. J., Li, J. Q., Yoneyama, H., Uchida, N., Fujita, J., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00276-4 · Cited by 114
Egan, C., Pang, A., Durda, D., Cheng, H., Wang, J. H.-C., & Fujita, D. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202233 · Cited by 108
Src Family Kinases: Potential Targets for the Treatment of Human Cancer and Leukemia
Warmuth, M., Damoiseaux, R. D., Liu, Y., Fabbro, D., & Gray, N. S. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454126 · Cited by 111
Xing, L., Venegas, A. M., Chen, A. Y.-C., Garrett-Beal, L. J., Boyce, B. F., VARMUS, H. E., & Schwartzberg, P. L. (2001) · Genes & Development · doi:10.1101/gad.840301 · Cited by 105
Dasatinib: An Anti-Tumour Agent via Src Inhibition
Gnoni, A., Marech, I., Silvestris, N., Vacca, A., & Lorusso, V. (2011) · Current Drug Targets · doi:10.2174/138945011794751591 · Cited by 103
Ritchie, S. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg246 · Cited by 97
Clinical Targeting of Mutated and Wild-Type Protein Tyrosine Kinases in Cancer
Drake, J. M., Lee, J. K., & Witte, O. N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-13 · Cited by 94
Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis
Wei, L., Yu, Y., Zhang, X., & Yu, Q. (2004) · Oncogene · doi:10.1038/sj.onc.1208091 · Cited by 91
Barbolina, M. V., Adley, B. P., Ariztia, E. V., Liu, Y., & Stack, M. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608428200 · Cited by 92
Staley, C. A., Parikh, N. U., & Gallick, G. E. (1997) · PubMed · Cited by 96
Kinase Inhibitors in Cancer Therapy
Sedlacek, H. H. (2000) · Drugs · doi:10.2165/00003495-200059030-00004 · Cited by 89
The Src Family of Protein Tyrosine Kinases: A New and Promising Target for Colorectal Cancer Therapy
Lieu, C. H., & Kopetz, S. (2010) · Clinical Colorectal Cancer · doi:10.3816/ccc.2010.n.012 · Cited by 87
Mitchell, L. A., Nixon, B., Baker, M. A., & Aitken, R. J. (2008) · Molecular Human Reproduction · doi:10.1093/molehr/gan007 · Cited by 86
Read, R. D., Bach, E. A., & Cagan, R. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6676-6689.2004 · Cited by 87
Health quality of life and colorectal cancer
PADILLA, G. V., GRANT, M. M., Lipsett, J. A., Anderson, P. R., Rhiner, M. I., & Bogen, C. (1992) · Cancer · doi:10.1002/1097-0142(19920901)70:3+ · Cited by 57
Systematic review of genetic influences on the prognosis of colorectal cancer
Anwar, S., Frayling, I. M., Scott, N., & Carlson, G. (2004) · British journal of surgery · doi:10.1002/bjs.4737 · Cited by 83
Reduced C–Terminal Src Kinase (Csk) Activities in Hepatocellular Carcinoma
Masaki, T., Okada, M., Tokuda, M., Shiratori, Y., Hatase, O., Shirai, M., Nishioka, M., & Omata, M. (1999) · Hepatology · doi:10.1002/hep.510290239 · Cited by 83
TAE226‐Induced apoptosis in breast cancer cells with overexpressed Src or EGFR
Golubovskaya, V., Virnig, C., & Cance, W. G. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20380 · Cited by 81
The sensors and regulators of cell–matrix surveillance in anoikis resistance of tumors
Nagaprashantha, L. D., Vatsyayan, R., Lelsani, P. C. R., Awasthi, S., & Singhal, S. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25725 · Cited by 84
Jones, R. J., Avizienyte, E., Wyke, A. W., Owens, D. W., Brunton, V. G., & Frame, M. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600594 · Cited by 80
RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints
Mamidipudi, V., Dhillon, N. K., Parman, T., Miller, L. D., Lee, K. C., & Cartwright, C. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210091 · Cited by 79
Self-citationThe multiple and enigmatic roles of guanylyl cyclase C in intestinal homeostasis
Arshad, N., & Visweswariah, S. S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.028 · Cited by 76
Lee, Y.-C., Huang, C.-F., Murshed, M., Chu, K., Araujo, J. C., Ye, X., deCrombrugghe, B., Yu-Lee, L.-Y., Gallick, G. E., & Lin, S.-H. (2010) · Oncogene · doi:10.1038/onc.2010.73 · Cited by 79
The cytoskeleton in development of epithelial cell polarity
Fath, K. R., Mamajiwalla, S. N., & Burgess, D. R. (1993) · Journal of Cell Science · doi:10.1242/jcs.1993.supplement_17.10 · Cited by 79
Bosutinib: A review of preclinical studies in chronic myelogenous leukaemia
Boschelli, F., Arndt, K. T., & Gambacorti-Passerini, C. B. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.032 · Cited by 80
pp60c-src Activation in hepatocellular carcinoma of humans and LEC rats
Masaki, T., Okada, M., Shiratori, Y., Rengifo, W., Matsumoto, K., Maeda, S., Kato, N., Kanai, F., Komatsu, Y., Nishioka, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270511 · Cited by 78
Regulation of both apoptosis and cell survival by the v-Src oncoprotein
Johnson, D., Agochiya, M., Samejima, K., Earnshaw, W. C., Frame, M. C., & Wyke, J. A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400700 · Cited by 82
Molecular mechanisms of hepatic metastasis in colorectal cancer
Rudmik, L. R., & Magliocco, A. M. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20393 · Cited by 76
Novel protein kinases expressed in human breast cancer
Cance, W. G., Craven, R. J., Weiner, T. M., & Liu, E. T. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540409 · Cited by 76
Coexpression of IGF-1R and c-Src Proteins in Human Pancreatic Ductal Adenocarcinoma
Hakam, A., Fang, Q., Karl, R. C., & Coppola, D. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1026122421369 · Cited by 78
Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway
Rieger‐Christ, K., Lee, P., Zagha, R. M., Kosakowski, M., Moinzadeh, A., Stoffel, J. T., Ben‐Ze'ev, A., Libertino, J. A., & Summerhayes, I. C. (2004) · Oncogene · doi:10.1038/sj.onc.1207629 · Cited by 76
Crystal Structures of Active Src Kinase Domain Complexes
Breitenlechner, C. B., Kairies, N., Honold, K., Scheiblich, S., Koll, H., Greiter, E., Koch, S., Schäfer, W., Huber, R., & Engh, R. A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.023 · Cited by 76
Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement
Serrels, A., Canel, M., Brunton, V. G., & Frame, M. C. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.4.17290 · Cited by 74
The Src signaling pathway: a potential target in melanoma and other malignancies
Homsi, J., Cubitt, C. L., & DAUD, A. I. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.1.91 · Cited by 75
Nutrient intake and gastric cancer in Mexico
Carrillo, L. L., López‐Cervantes, M., Ward, M. H., Bravo-Alvarado, J., & Ramírez‐Espitia, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991126)83:5 · Cited by 96
Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide
Jiang, X., Zhao, B., Britton, R., Lim, L. Y., Leong, D., Sanghera, J. S., Zhou, B. S., Piers, E., Andersen, R. J., & Roberge, M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1221.3.10 · Cited by 72
Parseghian, C. M., Parikh, N. U., Wu, J. Y., Jiang, Z.-Q., Henderson, L., Tian, F., Pastor, B., Ychou, M., Raghav, K., Dasari, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3138 · Cited by 67
Ritchie, S. A., Boyd, M., Wong, J. W. H., & Bonham, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.847 · Cited by 68
Dickinson, S. I., Zhang, H. Q., Yuan, Z. Q., Cheng, J. Q., Karl, R. C., Jove, R., & Coppola, D. (2003) · Human Pathology · doi:10.1053/s0046-8177(03)00354-x · Cited by 67
Raju, R. V. S., Datla, R. S. S., Moyana, T. N., Kakkar, R., Carlsen, S. A., & Sharma, R. K. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007012622030 · Cited by 64
Wright, D. D., Sefton, B. M., & Kamps, M. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2429 · Cited by 63
Self-citationPark, S. I., Shah, A. N., Zhang, J., & Gallick, G. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1207 · Cited by 64
Marcotte, R., Zhou, L., Kim, H. L., Roskelly, C. D., & Muller, W. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01731-08 · Cited by 62
Miracco, C., Pacenti, L., Santopietro, R., BIAGIOLI, M., Fimiani, M., Perotti, R., Rubegni, P., Pirtoli, L., & Luzi, P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001101)88:3 · Cited by 23
Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon
Peña, S. V., Melhem, M. F., Meisler, A. I., & Cartwright, C. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90015-2 · Cited by 58
Self-citationIn vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia
Licato, L. L., Keku, T. O., Wurzelmann, J. I., Murray, S., Woosley, J. T., Sandler, R. S., & Brenner, D. A. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352861 · Cited by 58
Differing Src Signaling Levels Have Distinct Outcomes in Drosophila
Vidal, M., Warner, S., Read, R. D., & Cagan, R. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1376 · Cited by 58
Tonn, J., Kerkau, S., Hanke, A., Bouterfa, H., Mueller, J. G., Wagner, S., Vince, G. H., & Roosen, K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990301)80:5 · Cited by 142
Weber, T. K., Steele, G., & Summerhayes, I. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115956 · Cited by 57
Protein kinases in human breast cancer
Cance, W. G., & Liu, E. T. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00694751 · Cited by 56
Novel regulation and function of Src tyrosine kinase
Ma, Y. C., & Huang, X. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8438-2 · Cited by 58
The guanine nucleotide exchange factor Arhgef5 plays crucial roles in Src-induced podosome formation
Kuroiwa, M., Oneyama, C., Nada, S., & Okada, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.080291 · Cited by 59
SRC transcriptional activation in a subset of human colon cancer cell lines
Dehm, S. M., Senger, M.-A., & Bonham, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02354-1 · Cited by 55
Src Activity Increases and Yes Activity Decreases during Mitosis of Human Colon Carcinoma Cells
Park, J., & Cartwright, C. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2374 · Cited by 54
Self-citation
Metadata
- Authors
- Cartwright, C. A., Kamps, M. P., Meisler, A. I., Pipas, J. M., & Eckhart, W.
- Affiliations
- Salk Institute for Biological Studies (US)
- ORCID
- Pipas, J M
- Venue
- Journal of Clinical Investigation
- Published
- 1989-06-01
- Volume
- 83
- Issue
- 6
- Pages
- 2025-2033
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303927
- OpenAlex
- W2121881330
- Cited by
- 265
- References
- 72
- Citations by year
- 2024: 2 · 2023: 5 · 2022: 2 · 2021: 3 · 2020: 2 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 8 · 2013: 5 · 2012: 8
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 14195, CA-13884, CA-01040)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- Src kinase, tyrosine kinase, colon cancer, kinase activation, autophosphorylation, colonic mucosa, cancer cell lines, oncogene expression
- MeSH terms
- Carcinoma, Cell Line, Colonic Neoplasms, Enzyme Activation, Humans, Intestinal Mucosa, Phosphoproteins, Phosphorylation, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Retroviridae Proteins, Tumor Cells, Cultured, Tyrosine, Oncogene Protein pp60(v-src)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review